Institutional investors purchased a net $18.3 thousand shares of PRAN during the quarter ended December 2015. This may signal that the smart money is gaining interest in this company as the 1.13% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
MORGAN STANLEY & CO. LLC Bought 30.7 Thousand shares of Prana Biotechnology Ltd